CD44 and neoplasm: Combined with TCGA and CGGA cohort, TRIM56 was most closely correlated with LAIR1, CD44, PDCD1LG2 and CD274 (Figure 6E), and oncoplots were used to display the tumor mutation gene microlandscape of TRIM56 high expression group and low expression group (Figure 6F).